Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Altria Group, Inc. and its officers or directors [1] Group 1: Legal Investigation - Pomerantz LLP is representing investors of Altria Group, Inc. in an investigation regarding claims of securities fraud [1] - Investors are encouraged to contact Pomerantz LLP for more information about the investigation [1] Group 2: Stock Performance and Analyst Ratings - On April 2, 2025, Deutsche Bank downgraded Altria's stock rating from "Buy" to "Hold" due to regulatory uncertainties following a ruling by the U.S. International Trade Commission [3] - Following the downgrade, Altria's stock price decreased by $1.67, or 2.84%, closing at $57.12 per share on the same day [3]

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Zack ...

Market Overview - U.S. stock markets experienced severe volatility in April, with the S&P 500 and Dow falling by 3.2% and 0.8%, respectively, while the Nasdaq Composite gained 0.9% [1] - The volatility was attributed to President Trump's tariffs and trade-related policies, with economists warning of a near-term recession as U.S. GDP contracted for the first time in three years in Q1 2025 [2] Economic Indicators - Better-than-expected nonfarm payrolls data for April and optimism regarding U.S. government trade negotiations are expected to boost confidence in equities [3] Investment Opportunities - Recommended stocks for investment in May include Sprouts Farmers Market Inc. (SFM), Philip Morris International Inc. (PM), Sony Group Corp. (SONY), Agnico Eagle Mines Ltd. (AEM), and NatWest Group plc (NWG), all of which have shown double-digit returns in the past month and hold a Zacks Rank 1 (Strong Buy) [4][5] Company Analysis Sprouts Farmers Market Inc. (SFM) - Focus on product innovation, e-commerce, and private label offerings has led to better-than-expected Q4 2024 results, with both revenue and earnings growing year over year [9] - SFM expects net sales to rise between 10.5% and 12.5% in 2025, with comparable store sales anticipated to increase by 4.5-6.5% [10] - Expected revenue and earnings growth rates for the current year are 13.4% and 30.7%, respectively, with a 5.2% improvement in earnings estimates over the last week [11] Philip Morris International Inc. (PM) - Strong pricing power and an expanding smoke-free product portfolio are driving growth, with PM aiming to become substantially smoke-free by 2030 [13] - Anticipates positive volume growth for the fifth consecutive year, with an expected increase of 2%, and smoke-free products projected to grow by 12-14% [14] - Expected revenue and earnings growth rates for the current year are 8.1% and 13.7%, respectively, with a 4.6% improvement in earnings estimates over the last 30 days [15] Sony Group Corp. (SONY) - Growth is supported by strong performance in Game & Network Services, Music, and Financial Services, despite challenges in the Entertainment, Technology & Services unit [16] - Fiscal 2024 sales view raised to ¥13,200 billion from ¥12,710 billion, driven by momentum in Financial Services and G&NS units [17] - Expected revenue and earnings growth rates for the current year are 0.7% and 14.4%, respectively, with a 0.7% improvement in earnings estimates over the last week [18] Agnico Eagle Mines Ltd. (AEM) - Focus on production growth through project execution and strategic acquisitions, including the merger with Kirkland Lake Gold [19][20] - Expected revenue and earnings growth rates for the current year are 20.6% and 44.4%, respectively, with a 6.1% improvement in earnings estimates over the last week [20] NatWest Group plc (NWG) - Provides a range of banking and financial services across various segments, including Retail Banking and Private Banking [21][22] - Expected revenue and earnings growth rates for the current year are 10.8% and 12.8%, respectively, with a 2.7% improvement in earnings estimates over the last week [22]

The S&P 500 Index has been able to recoup all losses suffered due to the Trump administration’s tariff-led market mayhem at a lightning speed. On May 2, the broad-market index recorded a nine-day winning streak, for the first time since November 2004. With this, Wall Street’s most observed stock index recovered all losses since April 2, when President Donald Trump announced the imposition of reciprocal tariffs. The index is currently around 7% away from its all-time high recorded in February. During the tar ...

Core Viewpoint - Altria Group has maintained a strong dividend history, raising its dividend annually since 2009, with a current forward yield of 7%, but concerns exist regarding the sustainability of this dividend amid declining cigarette volumes and competition from alternative products [1][11]. Revenue and Volume Analysis - Cigarette smoking in the U.S. is declining due to health concerns and the rise of alternatives like vaping, with Altria's cigarette shipment volumes down 13.7% in Q1, including a 13.3% drop for Marlboro and a 24.9% plunge in discount brand shipments [2][3]. - Revenue from the smokeable segment fell 4.1% to $3.91 billion, although adjusted operating income rose 2.7% due to lower manufacturing costs [4]. - In the oral tobacco segment, shipment volumes decreased by 5% to 175.4 million cans, with overall revenue rising by 0.5% to $654 million, but adjusted operating income remained flat [5]. - Altria's Njoy vaping business saw consumable shipments increase by 23.9% to 13.5 million units, but device shipments fell 70% to 0.3 million units, indicating a mixed performance in the vaping segment [6]. Financial Health and Dividend Safety - Altria generated $2.72 billion in operating cash flow and $2.68 billion in free cash flow in the quarter, with a dividend payout of $1.73 billion, resulting in a coverage ratio of over 1.5 times based on free cash flow [9]. - The company ended the quarter with net debt of $21.3 billion and a leverage ratio of 1.7 times, indicating manageable debt levels [9]. Future Outlook - Altria maintained its full-year guidance for adjusted EPS between $5.30 and $5.45, reflecting growth of 2% to 5%, while acknowledging the impact of increased tariffs and cost inflation on consumer behavior [7]. - There are concerns that continued price increases may not be sustainable in the face of declining volumes, which could affect long-term profitability [10][12]. Market Position and Valuation - Altria's stock has performed well in a volatile market, but the overall cigarette business is declining, and its smoke-free products are not yet significant enough to offset this trend [11]. - The company trades at a forward P/E ratio of 11 based on 2025 analyst consensus, which is higher than British American Tobacco but lower than Philip Morris International, which is experiencing growth without facing similar volume declines [13].

Core Viewpoint - The stock market in 2025 has shifted towards value stocks, with British American Tobacco (BTI) showing resilience and a year-to-date increase of 17% in U.S. dollar terms, outperforming broader market indices [1][2]. Financial Performance - British American Tobacco offers a dividend yield of 7%, significantly higher than the market average, with potential for continued growth in dividend payouts [2]. - The company has maintained healthy free cash flow generation, exceeding $10 billion annually since 2020, with $11.9 billion generated last year and an expected cumulative free cash flow of $67 billion from 2024 to 2030 [4][5]. Market Dynamics - Despite a 5% decline in global cigarette volumes in 2024, British American Tobacco's combustibles segment reported flat organic revenue when adjusted for currency movements, indicating resilience in earnings [4]. - The company is investing in alternative nicotine products, such as pouches and vaping, to adapt to changing market conditions, with nicotine pouches generating around $6 billion in revenue last year [6][7]. Growth Opportunities - The smokeless segment has grown significantly, contributing billions in revenue annually, which is expected to offset declines in cigarette volumes and support free cash flow [8]. - The Vuse brand faces competitive pressure from illicit disposable vaping devices, but potential regulatory crackdowns could facilitate a return to growth for Vuse [7]. Capital Management - British American Tobacco has utilized its free cash flow to pay down debt and engage in share repurchases, reducing shares outstanding by 3.4% over the last four years, which aids in growing the dividend per share [11]. - The company is positioned to sustainably grow its dividend per share due to ample free cash flow accumulation [10][11].

Core Viewpoint - Altria Group Inc. reported mixed first-quarter 2025 results, with a decline in top-line revenue but an increase in bottom-line earnings, reaffirming its 2025 adjusted EPS guidance [1][2]. Financial Performance - Adjusted earnings per share (EPS) for the first quarter were $1.23, a 6% increase year over year, surpassing the Zacks Consensus Estimate of $1.17 [2]. - Net revenues totaled $5,259 million, down 5.7% year over year, missing the consensus estimate of $4,638.2 million [2]. - Revenues from smokeable products fell 5.8% to $4,622 million, primarily due to reduced shipment volume, although higher pricing provided some offset [4]. Segment Analysis - **Smokeable Products**: - Net revenues decreased 5.8% year over year to $4,622 million, with domestic cigarette shipment volumes down 13.7% [4][5]. - Adjusted operating income (OCI) increased 2.7% to $2,518 million, with adjusted OCI margins growing 4.2 percentage points to 64.4% [6]. - **Oral Tobacco Products**: - Net revenues rose 0.5% to $654 million, driven by higher pricing, despite a 5% decline in domestic shipment volumes [7][8]. - Adjusted OCI remained flat, with a slight decline in adjusted OCI margin by 0.3 percentage points to 69.2% [9]. Shareholder Returns and Guidance - The company repurchased 5.7 million shares for $326 million in the first quarter, with $674 million remaining under its $1 billion share repurchase program [11]. - Altria expects 2025 adjusted EPS in the range of $5.30 to $5.45, reflecting a year-over-year growth of 2% to 5% from a base of $5.19 in 2024 [12][13]. Market Context - Altria's stock has gained 12.6% over the past three months, compared to the industry's growth of 21.8% [15].

Group 1 - The article discusses the author's enjoyment in researching British American Tobacco (NYSE: BTI) as a significant investment holding [1] - The author emphasizes a value investing approach, focusing on undervalued companies with a strong margin of safety and attractive dividend yields [1] - The author highlights a preference for companies with a solid earnings track record trading at less than 8 times free cash flow, which reflects a specific investment strategy [1] Group 2 - The author has a beneficial long position in British American Tobacco shares, indicating a personal investment interest [2] - The article expresses the author's own opinions without external compensation, suggesting an independent analysis [2] - There is no business relationship with any company mentioned, reinforcing the objectivity of the analysis [2]

Join for a 100% Risk-Free trial and see if our proven method can help you too. You do not need to pay for the costly lessons from the market itself.The last time I analyzed Altria Group (NYSE: MO ) stock, I rated it as a hold, with a focus on its technical trading indicators. To wit, that article was titled "Altria IsSensor Unlimited contributes to the investing group Envision Early Retirement which is led by Sensor Unlimited. They offer proven solutions to generate both high income and high growth with iso ...

Press ReleaseKaiseraugst (Switzerland), Maastricht (Netherlands), April 30, 2025 dsm-firmenich Q1 2025 trading update Management Report Q1 2025 highlights Good start to the year with strong organic sales and earnings growthProgressing well on 2025 strategic planSale of Feed Enzymes business for €1.5 billion announcedAnimal Nutrition & Health exit process advancing as planned€1 billion share buyback program commenced in AprilFY 2025 outlook unchanged: Adjusted EBITDA at least €2.4 billion Key figures in € ...